Massive GDPR Fines Highlight Importance of Pseudonymization Controls for Clinical Research
Executive Summary
Gary LaFever discusses the EU General Data Protection Regulation and explains why life sciences companies should consider adopting GDPR-compliant pseudonymization technology.